Heart Failure
9 competing products in clinical development for Heart Failure.
Pipeline by Phase
Pre-clinical3
Phase 12
Phase 1/21
Phase 31
Approved2
All Products (9)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| SGLT2i, beta blocker, ARNI, MRA, MTD | Eli Lilly | Approved | Completed | 43 |
| Conivaptan | Astellas Pharma | Approved | Withdrawn | 35 |
| Stepped pharmacologic care | Nuwellis | Phase 3 | Completed | 30 |
| INXN-4001 | Precigen | Phase 1 | Completed | 23 |
| TRV120027 + Placebo | Trevena | Phase 1/2 | Completed | 22 |
| Edoxaban | Daiichi Sankyo | Pre-clinical | UNKNOWN | 22 |
| Conivaptan + Furosemide + Conivaptan and furosemide | Astellas Pharma | Pre-clinical | UNKNOWN | 22 |
| TRV120027 + Normal Saline | Trevena | Phase 1 | Completed | 19 |
| IV Loop Diuretics (LD) | Nuwellis | Pre-clinical | Terminated | 8 |